Replies to post #73 on Amplia Therapeutics Ltd. (INNMF)

[Smilin_B]

This is good news for a nice morning gap up on the shares. All day long market-makers have been soaking up shares at .04

[Trend-Setter]

OOppps. Did not notice it's Wednesday there already. I guess CC is done? Unless it is scheduled the following day.

[Smilin_B]

TO ALL

This was the news that sent the shares down 92% in one session:

http://www.innateimmunotherapeutics.com/irm/PDF/1424_0/TopLineResultsforTrialofMIS416

At the bottom you will see that it states

Investor conference call

An investor conference call will be held at 10.30am AEST.

Conference code: 832946

Dial in numbers:

United States: [phone]

Furthermore, the stock reacted as if "THE SHOW IS OVER" when in fact, it isn't:

"Innate Immunotherapeutics will also need to review the future of its MIS416 Compassionate Use Program. As there were no dose limiting safety concerns reported, the Company has received clinical advice that there is no immediate need to halt this program. The Company expects to be able to update program participants and their health practitioners of our decision pertaining to the MIS416 compassionate use program in about a month"

A precipitous drop from the .45 to .023/share is simply insane/overdone

This company has over $6,000,000 in cash and the study is not dead. As it states in the paragraph above, "there is no immediate need to halt this program"

Email Investor relations your concerns to Ms. Rebecca Wilson at the following email address:

[e-mail]